China’s mHealth Industry – A Bubble Waiting To Burst?
This article was originally published in PharmAsia News
In the Chinese internet industry, one of the most heard buzzwords at the moment is mHealth (mobile health). The number of mHealth Apps in the country is already staggering, with 5,000 predicted to be available by the end of 2015, versus just 2,000 in 2013. But is the field already a bubble preparing to burst given underlying challenges?
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.